Heath(Samuel) & Sons - Director/PDMR Shareholding

Samuel Heath and Sons

18/12/2019 07:00

RNS Number : 2299X

Heath(Samuel) & Sons PLC

18 December 2019

 

Samuel Heath & Sons plc

 

("Samuel Heath" or "the Company")

 

PDMR/PCA Dealing

 

The Company was informed on 17 December 2019 that Mr Martin Harrison, Director of the Company, purchased 1,000 ordinary shares in the Company at a price of 325p on 17 December 2019.

As a result, Mr Harrison is interested in a total of 1,000 ordinary shares in the Company representing approximately 0.04% of its issued ordinary share capital.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For further information, please contact:

Samuel Heath & Sons plc
Simon Latham, Company Secretary
+44 (0)121 766 4200


 

Cairn Financial Advisers LLP
James Caithie / Jo Turner
+44(0) 20 7213 0880


 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1
Details of the person discharging managerial responsibilities/person closely associated
a.
Name
Martin John Harrison
2
Reason for notification
Purchase of Shares
a.
Position/Status
Director
b.
Initial notification/
Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
HEATH (SAMUEL) & SONS PLC
b.
LEI
213800LZPSLF8Z5NQS39
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the financial instrument, type of instrument

 Identification Code

Ordinary Shares
ISIN: GB0004178710
b.
Nature of the transaction
Purchase of ordinary shares
c.
Price(s) and volume(s)
Price(s) per share
Volume(s)
325p
1,000
d.
Aggregated information
- Aggregated Volume
- Price
n/a
n/a
e.
Date of the transaction
17 December 2019
f.
Place of the transaction
AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

 

END

 

 

DSHBRBDDBDBBGCR